SOX2 and ovarian cancer: Treatment with CM37, a small molecule with inhibitory activity against ALDH1A1, suppressed spheroid proliferation of ovarian cancer cells and reduced expression of OCT4 and SOX2 in ALDH+ cells in ascites and ovarian cancer cell lines[97].